Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transform...
Saved in:
Published in | PloS one Vol. 11; no. 11; p. e0166433 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
15.11.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
ISSN | 1932-6203 1932-6203 |
DOI | 10.1371/journal.pone.0166433 |
Cover
Abstract | Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.
Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.
ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.
ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. |
---|---|
AbstractList | Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.BACKGROUNDAlternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.METHODSCultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.RESULTSET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.CONCLUSIONET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET.sub.A and ET.sub.B). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET.sub.A/B RA, bosentan 10.sup.-5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET.sub.A/B RA treatment in both cultured cell types. ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET.sub.A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET.sub.A and ET.sub.B). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET.sub.A/B RA, bosentan 10.sup.-5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET.sub.A/B RA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET.sub.A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET A and ET B ). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET A/B RA, bosentan 10 -5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET A/B RA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes. |
Audience | Academic |
Author | Sulli, Alberto Soldano, Stefano Ruaro, Barbara Trombetta, Amelia Chiara Montagna, Paola Pizzorni, Carmen Cutolo, Maurizio Paolino, Sabrina Brizzolara, Renata |
AuthorAffiliation | Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy Universitatsklinikum Freiburg, GERMANY |
AuthorAffiliation_xml | – name: Universitatsklinikum Freiburg, GERMANY – name: Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy |
Author_xml | – sequence: 1 givenname: Stefano surname: Soldano fullname: Soldano, Stefano – sequence: 2 givenname: Carmen surname: Pizzorni fullname: Pizzorni, Carmen – sequence: 3 givenname: Sabrina surname: Paolino fullname: Paolino, Sabrina – sequence: 4 givenname: Amelia Chiara surname: Trombetta fullname: Trombetta, Amelia Chiara – sequence: 5 givenname: Paola surname: Montagna fullname: Montagna, Paola – sequence: 6 givenname: Renata surname: Brizzolara fullname: Brizzolara, Renata – sequence: 7 givenname: Barbara surname: Ruaro fullname: Ruaro, Barbara – sequence: 8 givenname: Alberto surname: Sulli fullname: Sulli, Alberto – sequence: 9 givenname: Maurizio surname: Cutolo fullname: Cutolo, Maurizio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27846260$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl2LEzEUhgdZcT_0H4gOeLNetOZrkowXQimrW9hFL_Q65GvalDSpM5mF_nsz26m0yyKSi4ST57w5eXkvi7MQgy2KtxBMIWbw0zr2bZB-us3lKYCUEoxfFBewxmhCEcBnR-fz4rLr1gBUmFP6qjhHjBOKKLgo_Mwnm3WSe7B-V850PshkTXl9jz6W91K3cbuSS1v-WNkQ025ry0VXLoLptVPelmpX3gQT08p6FyawdKGc9z71bZa47TcyHGl0r4uXjfSdfTPuV8Wvrzc_57eTu-_fFvPZ3UTTGqWJbjjXKs8NK6glalRDQcMYw6aCEFS1rpVUFiigGEMQm4YrhDlr8r0lGht8Vbzf62597MRoVCcgJxBWtGYgE4s9YaJci23rNrLdiSideCzEdilkm5z2VtREIco0sgZJohujKCAaUGwxrw1WOmt9GV_r1cYabUNqpT8RPb0JbiWW8UHk3yBe4SxwPQq08XdvuyQ2rtPWexls7B_npgQSgsl_oLhmmFI-oB-eoM8bMVJLmf_qQhPziHoQFTPCIKeYI56p6TNUXsZunM4BbFyunzS8O_bkrxmH4GXg8x7I4ei61jZCu5RTGAeLnBcQiCHlh5nFkHIxpjw3kyfNB_1_tv0B9ZQCiQ |
CitedBy_id | crossref_primary_10_1016_j_colsurfb_2017_04_039 crossref_primary_10_1002_jor_25564 crossref_primary_10_1016_j_jmii_2020_07_022 crossref_primary_10_3389_fimmu_2023_1174249 crossref_primary_10_1016_j_intimp_2021_108083 crossref_primary_10_1093_ibd_izae155 crossref_primary_10_1016_j_tube_2020_102039 crossref_primary_10_1080_1744666X_2019_1614915 crossref_primary_10_3390_nu11071688 crossref_primary_10_1007_s10565_021_09652_7 crossref_primary_10_1016_j_taap_2021_115470 crossref_primary_10_1016_j_lungcan_2018_07_015 crossref_primary_10_1038_s41419_019_1656_4 crossref_primary_10_3389_fimmu_2019_02874 crossref_primary_10_1016_j_intimp_2022_108907 crossref_primary_10_1016_j_neo_2019_11_001 crossref_primary_10_1016_j_autrev_2019_102397 crossref_primary_10_1371_journal_pone_0175238 crossref_primary_10_1016_j_virusres_2020_197991 crossref_primary_10_1007_s43032_022_00890_6 crossref_primary_10_1099_jmm_0_000496 crossref_primary_10_1016_j_intimp_2022_109089 crossref_primary_10_3390_ijms19113562 crossref_primary_10_3389_fimmu_2024_1534823 crossref_primary_10_3390_ijms22031064 crossref_primary_10_1111_pcmr_13002 crossref_primary_10_3390_pathogens8040280 crossref_primary_10_1186_s12974_018_1164_y crossref_primary_10_1111_exd_70014 crossref_primary_10_3390_ph16040569 crossref_primary_10_1002_hep_29346 crossref_primary_10_3389_fimmu_2020_01167 crossref_primary_10_1165_rcmb_2021_0504OC crossref_primary_10_1016_j_autrev_2017_05_024 crossref_primary_10_3389_fimmu_2019_01858 crossref_primary_10_3390_ijms23052509 crossref_primary_10_1177_10406387211053254 crossref_primary_10_3390_genes12030445 crossref_primary_10_1016_j_cellimm_2018_07_008 crossref_primary_10_1016_j_ebiom_2019_01_067 crossref_primary_10_3389_fimmu_2017_01242 crossref_primary_10_3389_fimmu_2017_00693 crossref_primary_10_1038_s41537_017_0042_4 crossref_primary_10_1002_art_42061 crossref_primary_10_3389_fimmu_2022_936995 |
Cites_doi | 10.1055/s-0030-1255354 10.1016/j.immuni.2014.06.010 10.1038/labinvest.2010.73 10.1038/nrrheum.2015.111 10.1016/j.jaut.2009.09.012 10.1371/journal.pgen.1003291 10.1371/journal.pone.0118010 10.1152/ajprenal.00421.2006 10.3899/jrheum.081030 10.1186/s13098-015-0108-2 10.1016/j.clinre.2015.09.005 10.1371/journal.pone.0081382 10.1038/labinvest.2013.69 10.1111/j.1600-0625.2008.00828.x 10.1038/nri2448 10.1186/s12885-015-1546-9 10.1016/j.clim.2010.06.017 10.1016/j.immuni.2014.06.008 10.1038/nature12034 10.1016/j.jdermsci.2016.05.015 10.1016/j.febslet.2009.04.027 10.1016/S1471-4906(02)02302-5 10.1186/ar3066 10.1016/S1499-3872(14)60261-7 10.1038/nm.2807 10.1164/rccm.200509-1518OC 10.1111/exd.12727 10.1093/hmg/ddn376 10.1016/j.canlet.2014.05.008 10.1002/art.30318 10.1016/j.imbio.2005.05.010 10.1006/meth.2001.1262 10.1152/ajplung.00474.2004 10.1007/s11926-015-0554-8 10.1038/nri3073 10.1016/j.jim.2007.10.003 10.1007/s12026-012-8291-9 10.3899/jrheum.150088 10.1164/rccm.201010-1719OC 10.1038/labinvest.2013.3 10.3899/jrheum.141070 10.5527/wjn.v2.i3.84 10.1002/path.4133 10.1371/journal.pone.0149276 10.3389/fphar.2012.00119 10.1189/jlb.1012512 10.1111/acel.12350 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2016 Public Library of Science 2016 Soldano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Soldano et al 2016 Soldano et al |
Copyright_xml | – notice: COPYRIGHT 2016 Public Library of Science – notice: 2016 Soldano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Soldano et al 2016 Soldano et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0166433 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Proquest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Materials Science & Engineering ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Database ProQuest Central Technology Collection (via ProQuest SciTech Premium Collection) Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database (Proquest) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Biological Science Engineering Database (Proquest) Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic Agricultural Science Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Medicine |
DocumentTitleAlternate | Endothelin-1 Effects on Cultured Macrophages |
EISSN | 1932-6203 |
ExternalDocumentID | 1841156970 oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc PMC5112853 4254121321 A471863828 27846260 10_1371_journal_pone_0166433 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM AAPBV ABPTK |
ID | FETCH-LOGICAL-c692t-cf88cb620151ca2fbf60f7773d511059c9babe0b0b77213df8b2387f3d5e4c3d3 |
IEDL.DBID | DOA |
ISSN | 1932-6203 |
IngestDate | Sun Sep 03 00:14:19 EDT 2023 Wed Aug 27 01:23:58 EDT 2025 Thu Aug 21 13:49:29 EDT 2025 Sun Sep 28 14:48:31 EDT 2025 Mon Sep 08 04:17:13 EDT 2025 Fri Jul 25 10:20:32 EDT 2025 Tue Jun 17 20:49:40 EDT 2025 Tue Jun 10 20:36:08 EDT 2025 Thu Apr 03 07:08:46 EDT 2025 Tue Jul 01 01:05:14 EDT 2025 Thu Apr 24 22:58:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c692t-cf88cb620151ca2fbf60f7773d511059c9babe0b0b77213df8b2387f3d5e4c3d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceptualization: SS MC.Data curation: SS PM RB.Formal analysis: SS ACT PM RB.Investigation: SS.Methodology: SS PM RB.Project administration: SS.Resources: CP SP BR AS.Software: ACT.Supervision: MC.Validation: MC.Visualization: MC.Writing – original draft: SS MC.Writing – review & editing: CP SP BR AS. |
OpenAccessLink | https://doaj.org/article/94b267c2ed2a4cfdb604c063e389d3bc |
PMID | 27846260 |
PQID | 1841156970 |
PQPubID | 1436336 |
ParticipantIDs | plos_journals_1841156970 doaj_primary_oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc pubmedcentral_primary_oai_pubmedcentral_nih_gov_5112853 proquest_miscellaneous_1846414434 proquest_miscellaneous_1839736684 proquest_journals_1841156970 gale_infotracmisc_A471863828 gale_infotracacademiconefile_A471863828 pubmed_primary_27846260 crossref_citationtrail_10_1371_journal_pone_0166433 crossref_primary_10_1371_journal_pone_0166433 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-11-15 |
PublicationDateYYYYMMDD | 2016-11-15 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2016 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | M Cutolo (ref24) 2013; 31 MA Gibbons (ref27) 2011; 184 KT Tan (ref49) 2013; 93 E Tinazzi (ref15) 2015; 2015 M Novak (ref34) 2013; 93 PJ Murray (ref5) 2011; 11 JM Catania (ref50) 2007; 292 CY Liu (ref40) 2013; 93 G Stifano (ref4) 2016; 18 QM Fan (ref45) 2014; 352 CA Beamer (ref28) 2005; 289 KJ Livak (ref22) 2001; 25 JA Araujo (ref19) 2012; 3 R Noy (ref43) 2014; 41 TA Wynn (ref7) 2012; 18 SK Biswas (ref3) 2012; 53 RB Christmann (ref32) 2011; 63 M Cutolo (ref51) 2015; 11 D Fairweather (ref8) 2009; 33 M Manetti (ref37) 2015; 24 SK Mathai (ref29) 2010; 90 BO Fabriek (ref31) 2005; 210 H Zhao (ref44) 2013; 2 J Kurzepa (ref47) 2014; 13 M Genin (ref17) 2015; 15 M Cutolo (ref14) 2015; 42 Y Wang (ref35) 2015; 14 T Fujimura (ref42) 2016; 83 A Mantovani (ref41) 2002; 23 M Stahl (ref26) 2013; 8 DM Mosser (ref6) 2008; 8 O Hashimoto (ref20) 2016 A Sulli (ref11) 2009; 36 N Higashi-Kuwata (ref9) 2010; 12 CL Lino Cardenas (ref46) 2013; 9 TA Wynn (ref2) 2013; 496 DV Pechkovsky (ref33) 2010; 137 A Prasse (ref30) 2006; 173 JY Park (ref39) 2016; 40 PJ Murray (ref21) 2014; 41 ME Tulapurkar (ref23) 2015; 10 N Higashi-Kuwata (ref10) 2009; 18 TA Wynn (ref48) 2010; 30 P Cipriani (ref13) 2015; 42 A Mantovani (ref1) 2013; 229 C Dumrese (ref25) 2009; 583 M Shigeoka (ref38) 2013; 104 GM Gersuk (ref18) 2008; 329 AP Yu (ref12) 2015; 7 C Barisone (ref16) 2016; 11 SA Villalta (ref36) 2009; 18 26253167 - BMC Cancer. 2015 Aug 08;15:577 22418728 - Immunol Res. 2012 Sep;53(1-3):11-24 25475858 - Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):570-9 23459460 - PLoS Genet. 2013;9(2):e1003291 28358878 - PLoS One. 2017 Mar 30;12 (3):e0175238 19320738 - Exp Dermatol. 2009 Aug;18(8):727-9 21425123 - Arthritis Rheum. 2011 Jun;63(6):1718-28 26090478 - J Immunol Res. 2015;2015:147616 23358111 - Lab Invest. 2013 Apr;93(4):434-49 24295474 - Clin Exp Rheumatol. 2013 Nov-Dec;31(6):943-6 20404807 - Lab Invest. 2010 Jun;90(6):812-23 23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81 26260763 - Nat Rev Rheumatol. 2015 Oct;11(10):569-71 24892648 - Cancer Lett. 2014 Oct 1;352(2):160-8 23752129 - Lab Invest. 2013 Jul;93(7):844-54 22833723 - Front Pharmacol. 2012 Jul 19;3:119 26700912 - Curr Rheumatol Rep. 2016 Jan;18(1):2 19819674 - J Autoimmun. 2009 Nov-Dec;33(3-4):222-30 18996917 - Hum Mol Genet. 2009 Feb 1;18(3):482-96 20674506 - Clin Immunol. 2010 Oct;137(1):89-101 24278429 - PLoS One. 2013 Nov 20;8(11):e81382 27425378 - J Pathol. 2016 Oct;240(2):211-23 25593238 - J Rheumatol. 2015 Mar;42(3):456-63 25869115 - Exp Dermatol. 2015 Aug;24(8):576-8 21997792 - Nat Rev Immunol. 2011 Oct 14;11(11):723-37 20665377 - Semin Liver Dis. 2010 Aug;30(3):245-57 26508473 - Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):357-65 27291068 - J Dermatol Sci. 2016 Sep;83(3):167-73 16415274 - Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92 19369451 - J Rheumatol. 2009 Jun;36(6):1235-9 19029990 - Nat Rev Immunol. 2008 Dec;8(12):958-69 24255890 - World J Nephrol. 2013 Aug 6;2(3):84-9 17997408 - J Immunol Methods. 2008 Jan 1;329(1-2):157-66 21680953 - Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81 25659128 - PLoS One. 2015 Feb 06;10(2):e0118010 11846609 - Methods. 2001 Dec;25(4):402-8 26276964 - J Rheumatol. 2015 Oct;42(10):1808-16 19393649 - FEBS Lett. 2009 May 19;583(10):1637-43 12401408 - Trends Immunol. 2002 Nov;23(11):549-55 17190907 - Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11 16164022 - Immunobiology. 2005;210(2-4):153-60 25035953 - Immunity. 2014 Jul 17;41(1):49-61 15849212 - Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L186-95 25035950 - Immunity. 2014 Jul 17;41(1):14-20 26692905 - Diabetol Metab Syndr. 2015 Dec 10;7:111 23648122 - Cancer Sci. 2013 Aug;104(8):1112-9 26009878 - Aging Cell. 2015 Aug;14(4):678-88 23619691 - Nature. 2013 Apr 25;496(7446):445-55 26925780 - PLoS One. 2016 Feb 29;11(2):e0149276 20602758 - Arthritis Res Ther. 2010;12(4):R128 23096265 - J Pathol. 2013 Jan;229(2):176-85 22772564 - Nat Med. 2012 Jul 06;18(7):1028-40 |
References_xml | – volume: 30 start-page: 245 year: 2010 ident: ref48 article-title: Macrophages: master regulators of inflammation and fibrosis publication-title: Semin Liver Dis doi: 10.1055/s-0030-1255354 – volume: 41 start-page: 49 year: 2014 ident: ref43 article-title: Tumor-associated macrophages: from mechanisms to therapy publication-title: Immunity doi: 10.1016/j.immuni.2014.06.010 – volume: 90 start-page: 812 year: 2010 ident: ref29 article-title: Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype publication-title: Laboratory Investigation doi: 10.1038/labinvest.2010.73 – volume: 11 start-page: 569 year: 2015 ident: ref51 article-title: Therapy. Optimized treatment algorithms for digital vasculopathy in SSc publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.111 – volume: 33 start-page: 222 year: 2009 ident: ref8 article-title: Alternatively activated macrophages in infection and autoimmunity publication-title: J Autoimmun doi: 10.1016/j.jaut.2009.09.012 – volume: 9 start-page: e1003291 year: 2013 ident: ref46 article-title: miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1003291 – volume: 10 start-page: e0118010 year: 2015 ident: ref23 article-title: Bacterial lipopolysaccharide augments febrile-range hyperthermia-induced heat shock protein 70 expression and extracellular release in human THP1 cells publication-title: PLoS One doi: 10.1371/journal.pone.0118010 – volume: 292 start-page: 905 year: 2007 ident: ref50 article-title: Role of matrix metalloproteinases in renal pathophysiologies publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00421.2006 – volume: 104 start-page: 1112 year: 2013 ident: ref38 article-title: Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma publication-title: Cancer Cel – volume: 36 start-page: 1235 year: 2009 ident: ref11 article-title: Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis publication-title: J Rheumatol doi: 10.3899/jrheum.081030 – volume: 7 start-page: 111 year: 2015 ident: ref12 article-title: Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults publication-title: Diabetol Metab Syndr doi: 10.1186/s13098-015-0108-2 – volume: 40 start-page: 357 year: 2016 ident: ref39 article-title: Polarized CD163+tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer publication-title: Clin Res Hepatol Gastroenterol doi: 10.1016/j.clinre.2015.09.005 – volume: 8 start-page: e81382 year: 2013 ident: ref26 article-title: Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation publication-title: PLoS One doi: 10.1371/journal.pone.0081382 – volume: 93 start-page: 844 year: 2013 ident: ref40 article-title: M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway publication-title: Lab Invest doi: 10.1038/labinvest.2013.69 – volume: 18 start-page: 727 year: 2009 ident: ref10 article-title: Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma publication-title: Exp Dermatol doi: 10.1111/j.1600-0625.2008.00828.x – volume: 8 start-page: 958 year: 2008 ident: ref6 article-title: Exploring the full spectrum of macrophage activation publication-title: Nat Rev Immunol doi: 10.1038/nri2448 – volume: 15 start-page: 577 year: 2015 ident: ref17 article-title: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide publication-title: BMC Cancer doi: 10.1186/s12885-015-1546-9 – volume: 31 start-page: 943 year: 2013 ident: ref24 article-title: Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment publication-title: Clin Exp Rheumatol – volume: 137 start-page: 89 year: 2010 ident: ref33 article-title: Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction publication-title: Clin Immunol doi: 10.1016/j.clim.2010.06.017 – volume: 41 start-page: 14 year: 2014 ident: ref21 article-title: Macrophage activation and polarization: nomenclature and experimental guidelines publication-title: Immunity doi: 10.1016/j.immuni.2014.06.008 – volume: 496 start-page: 445 year: 2013 ident: ref2 article-title: Macrophage biology in development, homeostasis and disease publication-title: Nature doi: 10.1038/nature12034 – volume: 83 start-page: 167 year: 2016 ident: ref42 article-title: Tumor-associated macrophages in skin: how to treat their heterogeneity and plasticity publication-title: J Dermatol Sci doi: 10.1016/j.jdermsci.2016.05.015 – volume: 583 start-page: 1637 year: 2009 ident: ref25 article-title: The secreted Helicobacter cysteine-rich protein A causes adherence of human monocytes and differentiation into a macrophage-like phenotype publication-title: FEBS Lett doi: 10.1016/j.febslet.2009.04.027 – volume: 23 start-page: 549 year: 2002 ident: ref41 article-title: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes publication-title: Trends Immunol doi: 10.1016/S1471-4906(02)02302-5 – volume: 12 start-page: R128 year: 2010 ident: ref9 article-title: Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis publication-title: Arthritis Res Ther doi: 10.1186/ar3066 – volume: 13 start-page: 570 year: 2014 ident: ref47 article-title: Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/S1499-3872(14)60261-7 – volume: 18 start-page: 1028 year: 2012 ident: ref7 article-title: Mechanisms of fibrosis: therapeutic translation for fibrotic disease publication-title: Nat Med doi: 10.1038/nm.2807 – volume: 173 start-page: 781 year: 2006 ident: ref30 article-title: A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200509-1518OC – volume: 24 start-page: 576 year: 2015 ident: ref37 article-title: Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma publication-title: Exp Dermatol doi: 10.1111/exd.12727 – volume: 18 start-page: 482 year: 2009 ident: ref36 article-title: Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddn376 – volume: 352 start-page: 160 year: 2014 ident: ref45 article-title: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2014.05.008 – volume: 63 start-page: 1718 year: 2011 ident: ref32 article-title: Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension publication-title: Arthritis Rheum doi: 10.1002/art.30318 – volume: 210 start-page: 153 year: 2005 ident: ref31 article-title: The macrophage scavenger receptor CD163 publication-title: Immunobiology doi: 10.1016/j.imbio.2005.05.010 – volume: 25 start-page: 402 year: 2001 ident: ref22 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method publication-title: Method doi: 10.1006/meth.2001.1262 – volume: 289 start-page: 186 year: 2005 ident: ref28 article-title: Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00474.2004 – volume: 18 start-page: 2 year: 2016 ident: ref4 article-title: Macrophage involvement in systemic sclerosis: do we need more evidence? publication-title: Curr Rheumatol Rep doi: 10.1007/s11926-015-0554-8 – volume: 11 start-page: 723 year: 2011 ident: ref5 article-title: Protective and pathogenic functions of macrophage subsets publication-title: Nat Rev Immunol doi: 10.1038/nri3073 – volume: 329 start-page: 157 year: 2008 ident: ref18 article-title: Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1 publication-title: J Immunol Methods doi: 10.1016/j.jim.2007.10.003 – volume: 53 start-page: 11 year: 2012 ident: ref3 article-title: Macrophage polarization and plasticity in health and disease publication-title: Immunol Res doi: 10.1007/s12026-012-8291-9 – volume: 42 start-page: 1808 year: 2015 ident: ref13 article-title: The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-beta and may be blocked by macitentan, a dual endothelin-1 receptor antagonist publication-title: J Rheumatol doi: 10.3899/jrheum.150088 – volume: 184 start-page: 569 year: 2011 ident: ref27 article-title: Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201010-1719OC – volume: 93 start-page: 434 year: 2013 ident: ref49 article-title: Matrix metalloproteinase-9 of tubular and macrophages origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin publication-title: Lab Invest doi: 10.1038/labinvest.2013.3 – year: 2016 ident: ref20 article-title: Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development publication-title: J Pathol – volume: 42 start-page: 456 year: 2015 ident: ref14 article-title: Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts publication-title: J Rheumatol doi: 10.3899/jrheum.141070 – volume: 2 start-page: 84 year: 2013 ident: ref44 article-title: Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases publication-title: World J Nephrol doi: 10.5527/wjn.v2.i3.84 – volume: 2015 start-page: 147616 year: 2015 ident: ref15 article-title: Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis publication-title: J Immunol Res – volume: 229 start-page: 176 year: 2013 ident: ref1 article-title: Macrophage plasticity and polarization in tissue repair and remodelling publication-title: J Pathol doi: 10.1002/path.4133 – volume: 11 start-page: e0149276 year: 2016 ident: ref16 article-title: Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages publication-title: PLoS One doi: 10.1371/journal.pone.0149276 – volume: 3 start-page: 119 year: 2012 ident: ref19 article-title: Heme oxygenase-1, oxidation, inflammation and atherosclerosis publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00119 – volume: 93 start-page: 875 year: 2013 ident: ref34 article-title: Macrophage phenotypes during tissue repair publication-title: J Leukoc Biol doi: 10.1189/jlb.1012512 – volume: 14 start-page: 678 year: 2015 ident: ref35 article-title: Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide publication-title: Aging Cell doi: 10.1111/acel.12350 – reference: 17997408 - J Immunol Methods. 2008 Jan 1;329(1-2):157-66 – reference: 27291068 - J Dermatol Sci. 2016 Sep;83(3):167-73 – reference: 20404807 - Lab Invest. 2010 Jun;90(6):812-23 – reference: 27425378 - J Pathol. 2016 Oct;240(2):211-23 – reference: 20674506 - Clin Immunol. 2010 Oct;137(1):89-101 – reference: 25659128 - PLoS One. 2015 Feb 06;10(2):e0118010 – reference: 26925780 - PLoS One. 2016 Feb 29;11(2):e0149276 – reference: 20602758 - Arthritis Res Ther. 2010;12(4):R128 – reference: 21425123 - Arthritis Rheum. 2011 Jun;63(6):1718-28 – reference: 26253167 - BMC Cancer. 2015 Aug 08;15:577 – reference: 15849212 - Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L186-95 – reference: 19369451 - J Rheumatol. 2009 Jun;36(6):1235-9 – reference: 19393649 - FEBS Lett. 2009 May 19;583(10):1637-43 – reference: 24255890 - World J Nephrol. 2013 Aug 6;2(3):84-9 – reference: 21680953 - Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81 – reference: 22418728 - Immunol Res. 2012 Sep;53(1-3):11-24 – reference: 21997792 - Nat Rev Immunol. 2011 Oct 14;11(11):723-37 – reference: 23648122 - Cancer Sci. 2013 Aug;104(8):1112-9 – reference: 22833723 - Front Pharmacol. 2012 Jul 19;3:119 – reference: 24278429 - PLoS One. 2013 Nov 20;8(11):e81382 – reference: 23619691 - Nature. 2013 Apr 25;496(7446):445-55 – reference: 19029990 - Nat Rev Immunol. 2008 Dec;8(12):958-69 – reference: 25035953 - Immunity. 2014 Jul 17;41(1):49-61 – reference: 26692905 - Diabetol Metab Syndr. 2015 Dec 10;7:111 – reference: 24892648 - Cancer Lett. 2014 Oct 1;352(2):160-8 – reference: 20665377 - Semin Liver Dis. 2010 Aug;30(3):245-57 – reference: 16164022 - Immunobiology. 2005;210(2-4):153-60 – reference: 24295474 - Clin Exp Rheumatol. 2013 Nov-Dec;31(6):943-6 – reference: 17190907 - Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11 – reference: 19819674 - J Autoimmun. 2009 Nov-Dec;33(3-4):222-30 – reference: 26260763 - Nat Rev Rheumatol. 2015 Oct;11(10):569-71 – reference: 12401408 - Trends Immunol. 2002 Nov;23(11):549-55 – reference: 25475858 - Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):570-9 – reference: 25035950 - Immunity. 2014 Jul 17;41(1):14-20 – reference: 26090478 - J Immunol Res. 2015;2015:147616 – reference: 23459460 - PLoS Genet. 2013;9(2):e1003291 – reference: 26508473 - Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):357-65 – reference: 25869115 - Exp Dermatol. 2015 Aug;24(8):576-8 – reference: 25593238 - J Rheumatol. 2015 Mar;42(3):456-63 – reference: 19320738 - Exp Dermatol. 2009 Aug;18(8):727-9 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81 – reference: 18996917 - Hum Mol Genet. 2009 Feb 1;18(3):482-96 – reference: 16415274 - Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92 – reference: 23358111 - Lab Invest. 2013 Apr;93(4):434-49 – reference: 26276964 - J Rheumatol. 2015 Oct;42(10):1808-16 – reference: 28358878 - PLoS One. 2017 Mar 30;12 (3):e0175238 – reference: 23096265 - J Pathol. 2013 Jan;229(2):176-85 – reference: 26700912 - Curr Rheumatol Rep. 2016 Jan;18(1):2 – reference: 22772564 - Nat Med. 2012 Jul 06;18(7):1028-40 – reference: 23752129 - Lab Invest. 2013 Jul;93(7):844-54 – reference: 26009878 - Aging Cell. 2015 Aug;14(4):678-88 |
SSID | ssj0053866 |
Score | 2.441359 |
Snippet | Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204... Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger... Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e0166433 |
SubjectTerms | 12-O-Tetradecanoylphorbol-13-acetate Acetic acid Aging Antigens, CD - genetics Antigens, CD - immunology Antigens, Differentiation, Myelomonocytic - genetics Antigens, Differentiation, Myelomonocytic - immunology Biology and Life Sciences Cancer therapies CD163 antigen Cell Differentiation - drug effects Cell Line Chemokine CCL22 - genetics Chemokine CCL22 - immunology Cytokines Diabetes mellitus Diabetes mellitus (non-insulin dependent) Endothelin Endothelin 1 Endothelin Receptor Antagonists - pharmacology Endothelin-1 - pharmacology Fibrosis Gelatinase B Gene expression Gene Expression Regulation Genes Genetic aspects Genotype & phenotype Growth factors Humans Immunocytochemistry Interleukin 10 Interleukin 4 Interleukin-10 - genetics Interleukin-10 - immunology Interleukin-4 - pharmacology Interleukins Internal medicine Laboratories Lectins, C-Type - genetics Lectins, C-Type - immunology Macrophage Activation - drug effects Macrophages Macrophages - cytology Macrophages - drug effects Macrophages - immunology Mannose Mannose-Binding Lectins - genetics Mannose-Binding Lectins - immunology Markers Matrix Metalloproteinase 9 - genetics Matrix Metalloproteinase 9 - immunology Medicine Medicine and Health Sciences Metalloproteinase Monocytes Monocytes - cytology Monocytes - drug effects Monocytes - immunology Monosaccharides Pathogenesis Peripheral blood Phenotype Polymerase chain reaction Primary Cell Culture Receptor, Endothelin A - genetics Receptor, Endothelin A - immunology Receptors Receptors, Cell Surface - genetics Receptors, Cell Surface - immunology Research and Analysis Methods Rheumatology Scavenger receptors Scavenger Receptors, Class A - genetics Scavenger Receptors, Class A - immunology Scleroderma (Disease) Studies Sulfonamides - pharmacology Systemic sclerosis Tetradecanoylphorbol Acetate - pharmacology Transforming Growth Factor beta1 - genetics Transforming Growth Factor beta1 - immunology Transforming growth factor-b1 Transforming growth factors Type 2 diabetes Western blotting |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELZgkRAXRMujgYKMhER7SJvYjp2c0IK6FKRFHKjUWxQ_wq4UJUuzrdR_35nECQ2qynU98VrjeXz2eGYI-ZBwlkohZagLkYVCySTUieJh7DJmHbPMdRX4lj_k6Zn4fp6c-wu31j-rHGxiZ6htY_CO_BhOIgBeZKaiT5s_IXaNwuiqb6HxkDyKGUgSZoovvg6WGHRZSp8ux1V87HfnaNPU7gigDjhjPnFHXdX-0TbPNlXT3gU8_30_ecshLZ6Rpx5J0nm_9Tvkgat3yeOlj5Xvkh2vti098LWlD5-Tal75G8ArV13Tuem6mzlLD5bskC4LbOi1AhNDf65c3eD9LP3WUuzvYda6clRf05PaYtYWwNMwpuua9kU5YYouHnBrjvYFOVuc_PpyGvqGC6GRGduGpkxToyVggiQ2BSt1KaNSKcUtwDLAYSbThXaRjjRg8pjbMtXg8VUJ404YbvlLMquBuXuEgkcsMlsojGwL8IBZGSs4D0srnBQ6kgHhA99z46uRY1OMKu9CbApOJT0bc9yt3O9WQMLxq01fjeM_9J9xS0darKXd_dBc_M69auaZ0Ewqw5xlhTCl1TISBpCbAyxnuTYB-YgCkaPGwxJN4RMX4H-wdlY-R_8OwsfSgOxPKEFTzWR4D0VqWGmb_5Vp-HIQs7uH34_DOCk-jKtdc4k0ACi5lKm4j0ZIAQdnDjSveskdOYJxZzzTBkRNZHrCsulIvV51ZcgRqgPYe33_0t-QJyBPEtM342SfzLYXl-4t4Litftcp6w2MjUea priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaWcuGCWF4bWJCRkNg9pEpsx04OCBW0qwWpiAOV9hbFj9BKUVqaLqL_npnEiTaowIVrZuxE4xnPN554hpDXCWepFFKGuhBZKJRMQp0oHsYuY9Yxy1xbgW_-WV4txKfr5PqI9D1bvQCbg6Ed9pNabKvpz-_7d2Dwb9uuDSruB00369pNAcKAk-V3yF3wTQz1fC6GvAJYt5T-At2fRo4cVFvHf9itJ5tq3RyCor__UXnLRV0-IPc9tqSzThmOyZGrH5Jjb70NPfMlps8fkWpW-YPAH67a05lpm5w5S8_m7JzOC-zrtYSdhn5ZunqNx7T0Y0OxzYdZ6cpRvacXtcXLW4BSw5iuatrV5oQp2rTArTmax2RxefH1w1Xo-y6ERmZsF5oyTY2WAA2S2BSs1KWMSqUUt4DOAI6ZTBfaRTrSAM1jbstUg-NXJdCdMNzyJ2RSg0RPCAXHWGS2UJjgFuAIszJWEBZLK5wUOpIB4b2wc-OLkmNvjCpvM20KgpNOdjkuUe6XKCDhMGrTFeX4B_97XMeBF0tqtw_W22-5t9A8E5pJZZizrBCmtFpGwgCAcwDpLNcmIG9QC3JURfhEU_j7C_AeLKGVz9DNw27G0oCcjjjBYM2IfIJ61H9pk0OQDbhcZiqCkb1uHSa_Gsg4Kf4fV7v1DfIAruRSpuJvPEIKiJ858Dzt1HWQCKafMbQNiBop8khkY0q9WrbVyBGxA-Z79j9k_JzcA62TeNczTk7JZLe9cS8A9O30y9aOfwH9t1eh priority: 102 providerName: Scholars Portal |
Title | Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27846260 https://www.proquest.com/docview/1841156970 https://www.proquest.com/docview/1839736684 https://www.proquest.com/docview/1846414434 https://pubmed.ncbi.nlm.nih.gov/PMC5112853 https://doaj.org/article/94b267c2ed2a4cfdb604c063e389d3bc http://dx.doi.org/10.1371/journal.pone.0166433 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: HH5 dateStart: 20060101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KQ8 dateStart: 20060101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KQ8 dateStart: 20061001 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: ABDBF dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: GX1 dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8FG dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1932-6203 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M48 dateStart: 20061201 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBdbdtllrPuq1y5oMFh7cGtLsmQf05KsG6SUsUJuxvowCRgnzOmg_33fsxUTj7JedtEhelbE0_v4PX28R8iXhLNUCilDXYgsFEomoU4UD2OXMeuYZa7NwDe_lle34sciWeyV-sI7YV164I5x55nQTCrDnGWFMKXVMhIG_KoDT2u5Nmh9wY3tgqnOBoMWS-kfynEVn_t1Odusa3cGIAfcMB84ojZff2-VR5tq3TwGOf--ObnnimavySuPIemkm_sBeebqN-TAa2lDT3wq6dO3pJpUfsPvj6vu6cS0xcycpSdzdkrnBdbvWoJFoTdLV69xO5Z-byiW8zArXTmq7-m0tvhIC9BoGNNVTbscnDBEu_2_N0bzjtzOpr8ur0JfXyE0MmPb0JRparQECJDEpmClLmVUKqW4BRQGsMtkutAu0pEGCB5zW6YaHLwqod8Jwy1_T0Y1cPSQUHCARWYLhQfZAhxeVsYKwl9phZNCRzIgfMfs3Pjk41gDo8rbEzUFQUjHuxyXKPdLFJCw_2rTJd94gv4C17GnxdTZ7Q8gULkXqPwpgQrIV5SCHBUcpmgK_04B_gdTZeUTdOdgtVgakOMBJSimGXQfohztZtrkEEwD_paZiuDLnWw93v2578ZB8R5c7dZ3SAP4kUuZin_RCCkgTuZA86ET154jeMyMIWxA1ECQBywb9tSrZZt1HJE5YLuP_4PHR-QlSJ3EN51xckxG29937hOAu60ek-dqoaBNL2NsZ9_G5MXF9Prm57jVcGjnIn0AtZVSwA |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIgEXRMujCwWMBKI9pE1sx04OCC3Qapd2Kw6t1FsaP8KuFCVLswXtn-I3MpPH0kVVOfWamTiWZzLzjceeIeRtyFkkhZSeTkXsCSVDT4eKe4GLmXXMMldX4Bsfy-Gp-HoWnq2R391dGDxW2dnE2lDb0uAe-R5EIgBeZKz8j7MfHnaNwuxq10KjUYtDt_gFIVv1YfQF5PuOsYP9k89Dr-0q4BkZs7lnsigyWoLjCwOTskxn0s-UUtwC9gCwYWKdaudrXwPwDLjNIg1uTWVAd8Jwy2HcO-Su4L7AWv3qbBngge2Qsr2ex1Ww12rD7qws3C5AK3D-fMX91V0Clr6gN8vL6jqg--95zSsO8OARedgiVzpoVG2drLlig9wbt7n5DbLemomKbre1rHcek3yQtzuOP12-oANTd1Nzlm6P2Q4dp9hAbAImjX6buKLE_WA6qij2EzFTnTuqF3S_sHhLDOCwF9BpQZsioDBEnX-4Mkb1hJzeiiiekl4Bi7tJKHjgNLapwky6AI8bZ4GC-Fta4aTQvuwT3q17Ytrq59iEI0_qlJ6CKKhZxgSllbTS6hNv-dasqf7xH_5PKNIlL9burh-UF9-T1hQksdBMKsOcZakwmdXSFwaQogPsaLk2ffIeFSJBCwNTNGl7UQK-g7W6kgHiCTCbLOqTrRVOsAxmhbyJKtXNtEr-_kPwZqdm15PfLMk4KB7EK1x5iTwAYLmUkbiJR0gBgToHnmeN5i5XBPPcGEP3iVrR6ZUlW6UU00ld9hxDAwCXz2-e-mtyf3gyPkqORseHL8gD0C2JV0eDcIv05heX7iVgyLl-Vf-4lJzftqX4A-LWhPI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkSZeEBsfKwwwEojtIWtjO3bzgFBhq1ZGpz0wqW9Z_BFaqUrK0oH6r_HXcZe4ZUHTeNprfHEs-_K73_nsO0LeRpz1pJAy0KmIA6FkFOhI8SB0MbOOWeaqDHyjU3l8Lr6Mo_EG-b26C4PHKleYWAG1LQzukXfAEwHyImPV7WT-WMTZ4eDj_EeAFaQw0roqp1GryIlb_gL3rfwwPIS1fsfY4Ojb5-PAVxgIjIzZIjBZr2e0BCMYhSZlmc5kN1NKcQs8BIiHiXWqXVd3NZDQkNusp8HEqQzanTDccuj3HrmvuOB4nEyN184e4IiU_qoeV2HHa8bBvMjdAdAsIAK8YQqrigFru9Caz4ryJtL779nNa8Zw8Ig89CyW9mu12yIbLt8mmyMfp98mWx4ySrrn81rvPyaz_szvPv50syXtm6qymrN0b8T26SjFYmITgDd6NnF5gXvDdFhSrC1ipnrmqF7So9zijTGgxkFIpzmtE4JCF1Us4lof5RNyfidL8ZS0cpjcHULBGqexTRVG1QVY3zgLFfji0gonhe7KNuGreU-Mz4SOBTlmSRXeU-AR1dOY4GolfrXaJFi_Na8zgfxH_hMu6VoW83hXD4rL74mHhSQWmkllmLMsFSazWnaFAdbogEdark2bvEeFSBBtYIgm9Zcm4DuYtyvpI7cACGW9NtltSAJKmEbzDqrUaqRl8vd_gjdXanZz85t1M3aKh_JyV1yhDJBZLmVP3CYjpACnnYPMs1pz1zOCMW_0p9tENXS6MWXNlnw6qVKgo5sARPP57UN_TTYBI5Kvw9OTF-QBqJbEW6RhtEtai8sr9xLo5EK_qv5bSi7uGij-ACIMiS0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alternatively+Activated+%28M2%29+Macrophage+Phenotype+Is+Inducible+by+Endothelin-1+in+Cultured+Human+Macrophages&rft.jtitle=PloS+one&rft.au=Stefano+Soldano&rft.au=Carmen+Pizzorni&rft.au=Sabrina+Paolino&rft.au=Amelia+Chiara+Trombetta&rft.date=2016-11-15&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=11&rft.issue=11&rft.spage=e0166433&rft_id=info:doi/10.1371%2Fjournal.pone.0166433&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |